Daptomycin (a recalls

The FDA has published 2 recalls involving Daptomycin (a since 2023. The latest was reported on 22 Feb 2023. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2023

Last 12 months0reported

Class I00% of total

Ongoing0latest 22 Feb 2023

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why daptomycin (a is recalled

Sterility2100%

Companies

Sentara Infusion Services2100%

By year

20232100%

All daptomycin (a recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
22 Feb 2023Drug	CLASS II	Daptomycin (a) 400MG IN NS, (b) 550MG IN NS, antibiotic recalled	Sentara Infusion Services	Sterility	Nationwide
22 Feb 2023Drug	CLASS II	Daptomycin (a)360MG in NS syringe recalled by Sentara Infusion Services	Sentara Infusion Services	Sterility	Nationwide

Should you stop taking Daptomycin (a?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.